Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
424studies shown
Showing 176-200 of 424
CompletedEUCTR 2019-001989-15

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of...

This study is comparing fremanezumab with placebo for people with Migraine and depression or Elderly. Participants receive fremanezumab or placebo and complete study visits and assessments.

DepressionOther
Countries
Germany, Czech Republic, France, Finland, Greece, Spain, Italy, View results
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Depression
OngoingEUCTR 2009-018277-31

EVALUATION DU RETENTISSEMENT PSYCHIATRIQUE, CARDIOVASCULAIRE ET SUR LA QUALITE DE VIE DE L’ HORMONOTHERAPIE FREINATRICE DANS UNE COHORTE DE PATIENTS THYROIDECTOMISES POUR CARCINOME THYROIDIEN PAPI...

This observational study is following people with Thyroidectomie pour carcinome papillaire différencié or Elderly to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Mental healthOther
Countries
France
Sponsor
CHU de Nîmes
Condition
Mental health
OngoingEUCTR 2007-007538-21

A Multi-center, Inpatient and ambulatory, Phase 2, Double-blind, Randomised, Placebo-controlled Proof of Concept Study of CYR-101 in Patients with DSM-IV Schizophrenia

This study is looking at care and outcomes for people with Diagnosis of Schizophrenia in Male or female, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised and confirmed by the St. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOther
Countries
France
Sponsor
CYRENAIC
Condition
Schizophrenia
OngoingEUCTR 2010-018416-33

Effets du Fénofibrate durant la première année de schizophrénie (effects of Fenofibrate® in first year of schizophrenia)

This study is looking at whether FENOFIBRATE MYLAN 200 mg, gélule can help people with schizophrénia or Elderly. Participants receive the study medicine FENOFIBRATE MYLAN 200 mg, gélule and complete study visits and assessments.

SchizophreniaOther
Countries
France
Sponsor
Centre Hospitalier Régional et Universitaire de Lille
Condition
Schizophrenia
CompletedEUCTR 2017-001447-12

A Multicenter, Randomized, Double-blind, Placebo- and Active controlled Trial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 years old) With Schizophr...

This study is comparing Brexpiprazole with placebo for people with Schizophrenia or Adolescents, Under 18. Participants receive Brexpiprazole or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Hungary, Spain, Poland, Bulgaria, France, Italy, Romania, View results
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
OngoingEUCTR 2020-003745-11

An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

This study is looking at whether None yet can help people with Schizophrenia. Participants receive the study medicine None yet and complete study visits and assessments.

SchizophreniaOther
Countries
France, Czech Republic, Spain, Slovakia, Hungary, Norway, Denmark, Lithuania, Italy, Greece, Belgium, Sweden, Netherlands, Finland, Croatia, Austria, Bulgaria, Portugal, Romania
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
OngoingEUCTR 2022-001515-10

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease Deme...

This study is comparing Trospium chloride with placebo for people with Psychosis Associated with Alzheimer’s Disease Dementia or Elderly. Participants receive Trospium chloride or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Spain, Slovakia, France, Italy, Bulgaria, Germany
Sponsor
Karuna Therapeutics
Condition
Schizophrenia
OngoingEUCTR 2017-002227-13

A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis

This study is comparing Pimavanserin with placebo for people with Hallucinations and Delusions Associated With Dementia-related Psychosis or Elderly. Participants receive Pimavanserin or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
United Kingdom, Czech Republic, Slovakia, Bulgaria, Spain, Poland, France, Italy, View results
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
CompletedNCT02794129

fMRI of Flight of Ideas in Bipolarity

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
CHU de Reims
Condition
Bipolarity
CompletedNCT01312649

Feeling of Being in Control of One's Own Action

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
CompletedNCT05922956

Facial Emotion Recognition in Patients With Euthymic Bipolarity I and II

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire, Amiens
Condition
Bipolarity
CompletedNCT06809881

OLFACTION AND BIPOLAR DISODER

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Bipolarity
CompletedNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression
CompletedNCT05650788

Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 40 Years
Countries
France
Sponsor
University Hospital, Clermont-Ferrand
Condition
Bipolarity
CompletedNCT05603819

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolarity, Based on RNA Editing Blood Biomarkers

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 80 Years
Countries
Denmark, France, Spain
Sponsor
Alcediag
Condition
Bipolarity
TerminatedNCT05161546

Study of Bipolarity and Retinal Electrophysiological Markers

This study exists to compare options and see whether the medication Bipolar offers something meaningfully different. Researchers are trying to understand whether the medication Bipolar can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Bipolarity
TerminatedNCT03508427

Toi Même: a Mobile System for Measuring Bipolar Illness

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut Pasteur
Condition
Bipolarity
CompletedNCT05965232

FIbrosis and Steatosis in Patients With Psychiatric Illness

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Esquirol
Condition
Bipolarity
CompletedNCT01644747

tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Condition
Depression